Trial Profile
A study investigating safety and efficacy of dabigatran when compared with warfarin in Aisan patients with nonvalvular atrial fibrillation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Jan 2016
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary) ; Warfarin
- Indications Gastrointestinal haemorrhage; Haemorrhage; Intracranial haemorrhages; Myocardial infarction; Stroke
- Focus Adverse reactions
- 22 Jan 2016 New trial record
- 05 Jan 2016 Results published in the Stroke